Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • FREE for Members
  • Contact hours
$10.00
JPHC CE: 0.75 contact hours. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Child maltreatment is a pediatric health care problem of epidemic proportions. Pediatric health care providers, especially pediatric nurse practitioners (PNPs), are uniquely positioned not only to identify potential victims of child maltreatment but also to prevent child maltreatment before its’ occurrence. This continuing education article will discuss practice level child maltreatment prevention interventions, both universal and targeted.
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 contact hour of which 1.25 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Clostridioides difficile infection (CDI) is a major public health concern for pediatric and adult patients. The management of pediatric CDI poses a challenge to healthcare providers due to lack of strong randomized controlled trials to guide pharmacological management. Additionally, recent updates to CDI guidelines recommend oral vancomycin over metronidazole for the management of CDI in adults, leaving questions regarding how to best manage pediatric patients. This continuing education pharmacotherapy review describes available evidence for the safety and efficacy of medications used in the treatment and management of pediatric CDI and aims to clarify discrepancies between pediatric and adult recommendations.
  • Primary Care
  • FREE for Members
  • Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. The gynecologic assessment in prepubertal children is an essential element of a thorough physical examination. It is not unusual for pediatric health care providers, including pediatric nurse practitioners (PNPs), to feel challenged by assessing for gynecologic signs and symptoms and performing a physical examination of the external genitalia in prepubertal girls (Bhoopatkar, Wearn, & Vnuk, 2017; Dabson, Magin, Heading, & Pond, 2014; McBain, Pullon, Garrett, & Hoare, 2016). The benefits of routine genital examinations have been discussed in the literature, including increasing patient and caregiver comfort with an examination, improved health care provider skill and confidence with examination and diagnostic assessment, providing a baseline for future examinations, and documentation of previously undiscovered anomalies (Johnson, 2002). This continuing education article will discuss genital examination preparation and techniques, normal prepubertal hymenal variants, common prepubertal gynecologic problems, and genital examination findings concerning abuse. J Pediatr Health Care. (2022) 36, 489-499
  • Primary Care
  • FREE for Members
  • Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Eating disorders are complex, potentially life-threatening conditions characterized by disruptive eating behaviors that significantly impact physical and psychosocial functioning. Eating disorders are associated with devastating medical complications and high mortality rates if left untreated. As the prevalence of eating disorders among adolescents continues to increase, it is important that clinicians are knowledgeable about early signs of disordered eating and facilitate timely evaluation and care coordination. The epidemiology, risk factors, and medical complications for common eating disorders in primary care such as anorexia nervosa, bulimia nervosa, and binge eating disorder, are presented. An approach to screening for eating disorders, clinical assessment, and treatment options are outlined. J Pediatr Health Care. (2022) 36, 618−627.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022) 36, 479−488